Connection
Joseph Saseen to Dyslipidemias
This is a "connection" page, showing publications Joseph Saseen has written about Dyslipidemias.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.305 |
|
|
|
-
Miller AE, Hansen LB, Saseen JJ. Switching statin therapy using a pharmacist-managed therapeutic conversion program versus usual care conversion among indigent patients. Pharmacotherapy. 2008 May; 28(5):553-61.
Score: 0.282
-
Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9.
Score: 0.282
-
Saseen J, Tweed E, Crawford P. Clinical inquiries. What are effective medication combinations for dyslipidemia? J Fam Pract. 2006 Jan; 55(1):70-2.
Score: 0.240
-
Nair KV, Saseen JJ. Quality assessment of dyslipidemia in managed care: current best evidence should be used to benchmark quality. Ann Pharmacother. 2006 Jan; 40(1):124-7.
Score: 0.239
-
Wiggins BS, Saseen JJ, Page RL, Reed BN, Sneed K, Kostis JB, Lanfear D, Virani S, Morris PB. Recommendations for Management of Clinically Significant Drug-Drug Interactions With Statins and Select Agents Used in Patients With Cardiovascular Disease: A Scientific Statement From the American Heart Association. Circulation. 2016 11 22; 134(21):e468-e495.
Score: 0.127
-
Tuchscherer RM, Nair K, Ghushchyan V, Saseen JJ. Simvastatin prescribing patterns before and after FDA dosing restrictions: a retrospective analysis of a large healthcare claims database. Am J Cardiovasc Drugs. 2015 Feb; 15(1):27-34.
Score: 0.113
-
Alford JC, Saseen JJ, Allen RR, Nair KV. Persistent use of against-label statin-fibrate combinations from 2003-2009 despite United States Food and Drug Administration dose restrictions. Pharmacotherapy. 2012 Jul; 32(7):623-30.
Score: 0.023